{"id":"NCT02068443","sponsor":"Takeda","briefTitle":"Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy","officialTitle":"A Phase 3 Multicenter, Randomized, Double-blind, Parallel-group, Comparative Study When Metformin Hydrochloride 500 mg is Added on to SYR-322 25 mg in Type 2 Diabetic Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2014-02-21","resultsPosted":"2016-06-06","lastUpdate":"2023-09-28"},"enrollment":374,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin","otherNames":["SYR-322","Nesina®"]},{"type":"DRUG","name":"Metformin hydrochloride","otherNames":["Glycoran®"]},{"type":"DRUG","name":"Metformin hydrochloride Placebo","otherNames":[]}],"arms":[{"label":"Alogliptin Alone","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin + Metformin Hydrochloride QD","type":"EXPERIMENTAL"},{"label":"Alogliptin + Metformin Hydrochloride BID","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the efficacy and safety of 24-week treatment with metformin hydrochloride 500 mg once daily added on to alogliptin (SYR-322) 25 mg in type 2 diabetic patients with inadequate glycemic control despite treatment with alogliptin 25 mg in addition to diet and exercise therapy.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin A1c (HbA1c) National Glycohemoglobin Standardization Program (NGSP) at the End of Treatment (EOT) Period","timeFrame":"Baseline and End of Treatment (EOT) (Up to Week 24)","effectByArm":[{"arm":"Alogliptin Alone","deltaMin":0.16,"sd":0.072},{"arm":"Alogliptin + Metformin Hydrochloride QD","deltaMin":-0.49,"sd":0.049},{"arm":"Alogliptin + Metformin Hydrochloride BID","deltaMin":-0.6,"sd":0.049}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":27,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":71},"commonTop":["Nasopharyngitis","Pharyngitis","Hypoaesthesia"]}}